What we do
Our mission is to make breast cancer screening more effective, measurable, and accessible. By enhancing early detection and ensuring outcomes backed by clinical evidence, we’re proud to contribute to a national effort focused on improving women’s health in Germany.
Founded in 2018 as the first company to emerge from Europe’s leading AI venture studio, Merantix, Vara has grown into an international team of 25 driven professionals. Our diverse team brings together entrepreneurs, healthcare experts, and technology innovators united by a common goal: transforming breast cancer screening for the better.
Further information can be found on our website: www.vara.ai